All In Biotech

Drug Trial Radar · NCT00271401

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percutaneous Coronary Intervention

Last checked: Nov 20, 2026Latest source record: May 25, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,399 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,399

Actual

Start

Jul 1996

Primary completion

Sep 1997

Study completion Sep 1997

Sponsor

Lead sponsor
Centocor, Inc.Johnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jan 2, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the effectiveness and safety of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention.

Conditions

  • Angioplasty, Transluminal, Percutaneous Coronary

Interventions

  • AngioplastyOther

  • Intracoronary StentOther

  • AbxicimabDrug

  • HeparinDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With any one of these: Deaths, Myocardial Infarctions, or Urgent Repeat RevascularizationsTime frame: Up to 30 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.